Back to 
TWO SIGMA INVESTMENTS, LP
TWO SIGMA INVESTMENTS, LP
IKT2 quarters
Position history for TWO SIGMA INVESTMENTS, LP's holdings in INHIBIKASE THERAPEUTICS INC
Yes. Two Sigma holds 806,264 shares of IKT (Inhibikase Therapeutics), worth $1.6M, as of its Q2 2026 13F filing. It reduced the position by 41,347 shares (-4.9%) from Q1 2026. Two Sigma has held IKT since Q1 2026, across 2 quarterly 13F filings.
Current Value
$1.6M
Current Shares
806,264
Total Value Change
+$212,730
Total Shares Change
-41,347
Quarter-by-Quarter History
Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC